Comerica Bank’s Utah Medical Products UTMD Stock Holding History

Comerica Bank’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$5.65K	Sell	101 -440	-81%	-$25.5K	﹤0.01%	3379
2025 Q3	$34.1K	Buy	541 +440	+436%	+$26K	﹤0.01%	2944
2025 Q2	$5.75K	Sell	101 -17	-14%	-$925	﹤0.01%	3344
2025 Q1	$6.61K	Buy	118 +70	+146%	+$4.19K	﹤0.01%	3273
2024 Q4	$2.95K	Sell	48 -170	-78%	-$11K	﹤0.01%	3412
2024 Q3	$14.6K	Buy	218 +40	+22%	+$2.71K	﹤0.01%	3099
2024 Q2	$11.9K	Buy	178 +74	+71%	+$5.04K	﹤0.01%	3124
2024 Q1	$7.39K	Sell	104 -27	-21%	-$2.02K	﹤0.01%	3250
2023 Q4	$11K	Buy	131 +16	+14%	+$1.33K	﹤0.01%	3129
2023 Q3	$9.87K	Buy	+115	New	+$10.6K	﹤0.01%	3210

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Comerica Bank's UTMD Position: Q4 2025 in Review

Comerica Bank reduced its Utah Medical Products (UTMD) stake by 81% in Q4 2025, selling an estimated $25.5K and leaving 101 shares worth $5.65K. The position accounts for ﹤0.01% of the portfolio, ranked #3379.

Comerica Bank first reported a position in UTMD in Q3 2023 and has held it in 10 quarters since. The position peaked at $34.1K in Q3 2025. 117 funds tracked by Wall St. Rank hold UTMD as of Q4 2025.

Comerica Bank held 101 shares of Utah Medical Products worth $5.65K as of Q4 2025.
Comerica Bank sold 440 Utah Medical Products shares in Q4 2025, an estimated $25.5K.
Utah Medical Products made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3379 holding.
Comerica Bank first reported a position in Utah Medical Products in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Utah Medical Products position peaked at $34.1K in Q3 2025.
117 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.